Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 10.86
Day High 12.00
Open:11.99
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth and has announced the acquisition of Redwood Holdings to sell CBD in the U.S.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Rapidly Expanding Cannabis Companies Flood the Job Market
- PR Newswire - Fri Oct 18, 8:00AM CDT
PR Newswire - CMTX
Fri Oct 18, 8:00AM CDT
As the cannabis industry begins to heat up, companies are beginning to aggressively seek employees to fill positions. Nearly two decades ago, cannabis was reintroduced into U.S. states such as California, Oregon, Alaska, and Washington. Since then, states like Michigan and Illinois decided to legalize adult-use of cannabis. Consequently, the rapid expansion of the market is creating a large influx of jobs. And according to a report by Glassdoor, there were a total of 1,512 cannabis industry job openings in December 2018, increasing by 76% compared to the same period a year ago. Moreover, ZipRecruiter highlighted that in 2017 the number of cannabis industry jobs grew by 445%, outpacing both the technology (254%) and healthcare (70%) industries. Furthermore, following the legalization of hemp-derived CBD products, industry experts noted that the job demand continued to grow. HempStaff, a hemp and cannabis recruiting firm, mentioned in March that 80% of its job listings are for upper-level positions such as Chief Financial Officers and accounting managers. However, HempStaff Chief Executive Officer James Yagielo also noted that as hemp factories begin to ramp up production rates, companies will need "factory line people, machinists and other types of workers." Additionally, positions such as accountants, lawyers, IT specialists, financial experts, researchers, and lab technicians are also in high demand. Glassdoor noted that brand ambassadors and sales associates each accounted for 5% of total cannabis job openings in 2018, which represented the largest shares for individual positions. On the other hand, the overall professional and technical jobs accounted for 53% of the job openings. Glassdoor also mentioned that the discrepancy is largely due to the wide range of available positions. However, as the industry continues to develop, various job positions are expected to see larger demand as businesses strive to comply with regulatory matters. As a result of the growing workforce, Fortune Business Insights projects that the global cannabis industry will grow from USD 10.6 Billion in 2018 to USD 97.35 Billion by the end of 2026. Additionally, the market is anticipated to grow at a CAGR of 32.6% during the forecast period. Newleaf Brands Inc. (OTC: NLBIF) (CSE: NLB), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), Planet 13 Holdings Inc. (OTC: PLNHF) (CSE: PLTH), Medmen Enterprises Inc. (OTC: MMNFF) (CSE: MMEN)
Canada Legalizes Cannabis Edibles, Beverages, Extracts and Other Derivative Products
- PR Newswire - Thu Oct 17, 7:30AM CDT
PR Newswire - CMTX
Thu Oct 17, 7:30AM CDT
On the first anniversary of Canadian cannabis legalization, "Legalization 2.0" or "Cannabis 2.0" will allow popular cannabis derivatives like edibles, infused beverages, and vapes to legally be bought and sold nationwide. Demand for these products is incredibly high, and most analysts believe that cannabis derivatives will allow companies to deliver on ambitious revenue projections for the still-growing pot industry. Because this market is so important, companies that are prepared to capitalize on cannabis-derived consumables--like BevCanna Enterprises Inc. (CSE:BEV) (OTCPK:BVNNF), MediPharm Labs Corp. (TSX:LABS) (OTCQX:MEDIF), Cronos Group (TSX:CRON) (NASDAQ:CRON), Valens GroWorks (TSXV:VGW) (OTCQX:VGWCF), and IAnthus Capital Holdings, Inc. (CSE:IAN) (OTCQX:ITHUF)--are likely to ride the new wave of legalization and become the major industry players of tomorrow.
Cronos Group Issues Statement on Separately Announced IPO of Cronos Australia
- GlobeNewswire - Wed Oct 16, 7:30AM CDT
GlobeNewswire - CMTX
Wed Oct 16, 7:30AM CDT
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") today noted the separately announced AUD$20 million initial public offering of Cronos Australia Limited ("Cronos Australia"). Under the offering, Cronos Australia is expected to issue 40 million new shares at an offering price of AUD$0.50 per share (the "Cronos Australia IPO") ahead of its planned listing on the Australian Securities Exchange in November 2019.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 10.17 +7.47% increase
on 10/11/19
Period Open:14.55
Price movement based on the high, low and last over the given period.
14.50 -24.62% decrease
on 09/19/19
-3.62 (-24.88%) decrease
since 09/18/19
3-Month 10.17 +7.47% increase
on 10/11/19
Period Open:19.46
Price movement based on the high, low and last over the given period.
20.72 -47.25% decrease
on 08/08/19
-8.53 (-43.83%) decrease
since 07/18/19
52-Week 8.47 +29.04% increase
on 10/30/18
Period Open:14.06
Price movement based on the high, low and last over the given period.
32.95 -66.83% decrease
on 02/04/19
-3.13 (-22.26%) decrease
since 10/18/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).